Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 805 is a putative transcription factor encoded by the ZNF805 gene in humans. It is predicted to enable DNA-binding, specifically through RNA polymerase II cis-regulatory sequences, and is likely active in the nucleus, modulating transcriptional processes. The gene is a member of the large zinc finger protein family, many of which function as transcriptional regulators implicated in a range of developmental and disease processes. Disease association for ZNF805 itself is minimal, though some gene-disease linkages for disorders like retinitis pigmentosa have been reported without strong causal evidence. No functional studies, interacting drugs, or therapeutic uses are known for this protein as of the latest available data. If more specific functional or disease-related detail emerges, or if ZNF805 is implicated in defined molecular or clinical contexts, these structured fields may be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 805 (ZNF805).